JP2016520656A - コルチコステロイド組成物 - Google Patents

コルチコステロイド組成物 Download PDF

Info

Publication number
JP2016520656A
JP2016520656A JP2016518385A JP2016518385A JP2016520656A JP 2016520656 A JP2016520656 A JP 2016520656A JP 2016518385 A JP2016518385 A JP 2016518385A JP 2016518385 A JP2016518385 A JP 2016518385A JP 2016520656 A JP2016520656 A JP 2016520656A
Authority
JP
Japan
Prior art keywords
propylene glycol
glyceryl
glycol
acetate
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016518385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520656A5 (enExample
Inventor
ラスロップ ロバート
ラスロップ ロバート
ウェイド オズボーン デイビッド
ウェイド オズボーン デイビッド
Original Assignee
トルマー，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by トルマー，インコーポレイティド filed Critical トルマー，インコーポレイティド
Publication of JP2016520656A publication Critical patent/JP2016520656A/ja
Publication of JP2016520656A5 publication Critical patent/JP2016520656A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2016518385A 2013-06-03 2014-06-02 コルチコステロイド組成物 Pending JP2016520656A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361830531P 2013-06-03 2013-06-03
US61/830,531 2013-06-03
PCT/US2014/040560 WO2014197398A1 (en) 2013-06-03 2014-06-02 Corticosteroid compositions

Publications (2)

Publication Number Publication Date
JP2016520656A true JP2016520656A (ja) 2016-07-14
JP2016520656A5 JP2016520656A5 (enExample) 2017-07-13

Family

ID=51014660

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016518385A Pending JP2016520656A (ja) 2013-06-03 2014-06-02 コルチコステロイド組成物

Country Status (9)

Country Link
EP (1) EP3003272A1 (enExample)
JP (1) JP2016520656A (enExample)
CN (1) CN105263474A (enExample)
AR (1) AR096459A1 (enExample)
AU (1) AU2014275195A1 (enExample)
CA (1) CA2912873A1 (enExample)
HK (1) HK1223300A1 (enExample)
MX (1) MX2015016603A (enExample)
WO (1) WO2014197398A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021504468A (ja) * 2017-11-27 2021-02-15 ウメクリン コグニチオン アーべー ３α−エチニル−３β−ヒドロキシアンドロスタン−１７−オンオキシムの医薬製剤

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011026076A2 (en) 2009-08-31 2011-03-03 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
ITUB20153460A1 (it) 2015-09-08 2017-03-08 Novamont Spa Composizioni cosmetiche acquose contenenti esteri dell?acido pelargonico
WO2023277616A1 (ko) * 2021-06-30 2023-01-05 주식회사 디네이쳐 중대가리풀 유래의 추출물을 포함하는 탈모기능성 조성물

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
JPH01165529A (ja) * 1987-11-23 1989-06-29 Alza Corp 皮膚透過促進剤としてグリセロールモノオレエートを用いる治療系
JPH04226922A (ja) * 1990-05-17 1992-08-17 Bristol Myers Squibb Co コントロール可能な皮膚浸透用局所組成物
JPH06256218A (ja) * 1993-03-04 1994-09-13 Lederle Japan Ltd 外用剤
JP2001505544A (ja) * 1996-09-11 2001-04-24 ティロッツ・ファルマ・アクチエンゲゼルシャフト フルオシノニド含有経口組成物
JP2001233772A (ja) * 2000-02-23 2001-08-28 Taiho Yakuhin Kogyo Kk 外用剤組成物
JP2002029965A (ja) * 2000-06-16 2002-01-29 Pacific Corp 親水性または塩の形態よりなる薬物を含有する経皮投与用製剤
JP2002519318A (ja) * 1998-06-26 2002-07-02 エルデイエス・テクノロジーズ・インコーポレーテツド 鼻および肺送達のためのコルチコステロイドを含有する水性組成物
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
JP2003506462A (ja) * 1999-06-25 2003-02-18 ダーハム ファーマシューティカルズ リミテッド 皮膚浸透剤を含む局所処方物およびその使用
JP2007526885A (ja) * 2003-07-07 2007-09-20 ネアーズ エービー マイクロエマルジョンおよび気道疾患を防ぐためのその使用
US20070264344A1 (en) * 2006-03-15 2007-11-15 Galderma S.A. Topically applicable anti-inflammatory O/W emulsions comprising pro-penetrating glycols
JP2007533697A (ja) * 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
JP2008522997A (ja) * 2004-12-09 2008-07-03 バイエル・ヘルスケア・アクチェンゲゼルシャフト 酸によるグルココルチコイドエステルの安定化
JP2008533052A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 抗ウイルス性組成物および使用方法
JP2009504619A (ja) * 2005-08-11 2009-02-05 ガルデルマ・ソシエテ・アノニム 皮膚科学における局所適用用水中油型エマルション
JP2010514748A (ja) * 2006-12-29 2010-05-06 アーダナ バイオサイエンス リミテッド 組成物の調製方法
WO2011154004A1 (en) * 2010-06-11 2011-12-15 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
CN102940594A (zh) * 2012-12-04 2013-02-27 艾能赛克机械设备(江苏)有限公司 一种头发调理剂
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
JPH01165529A (ja) * 1987-11-23 1989-06-29 Alza Corp 皮膚透過促進剤としてグリセロールモノオレエートを用いる治療系
JPH04226922A (ja) * 1990-05-17 1992-08-17 Bristol Myers Squibb Co コントロール可能な皮膚浸透用局所組成物
JPH06256218A (ja) * 1993-03-04 1994-09-13 Lederle Japan Ltd 外用剤
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
JP2001505544A (ja) * 1996-09-11 2001-04-24 ティロッツ・ファルマ・アクチエンゲゼルシャフト フルオシノニド含有経口組成物
JP2002519318A (ja) * 1998-06-26 2002-07-02 エルデイエス・テクノロジーズ・インコーポレーテツド 鼻および肺送達のためのコルチコステロイドを含有する水性組成物
JP2003506462A (ja) * 1999-06-25 2003-02-18 ダーハム ファーマシューティカルズ リミテッド 皮膚浸透剤を含む局所処方物およびその使用
JP2001233772A (ja) * 2000-02-23 2001-08-28 Taiho Yakuhin Kogyo Kk 外用剤組成物
JP2002029965A (ja) * 2000-06-16 2002-01-29 Pacific Corp 親水性または塩の形態よりなる薬物を含有する経皮投与用製剤
JP2007526885A (ja) * 2003-07-07 2007-09-20 ネアーズ エービー マイクロエマルジョンおよび気道疾患を防ぐためのその使用
JP2007533697A (ja) * 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
JP2008522997A (ja) * 2004-12-09 2008-07-03 バイエル・ヘルスケア・アクチェンゲゼルシャフト 酸によるグルココルチコイドエステルの安定化
JP2008533052A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 抗ウイルス性組成物および使用方法
JP2009504619A (ja) * 2005-08-11 2009-02-05 ガルデルマ・ソシエテ・アノニム 皮膚科学における局所適用用水中油型エマルション
US20070264344A1 (en) * 2006-03-15 2007-11-15 Galderma S.A. Topically applicable anti-inflammatory O/W emulsions comprising pro-penetrating glycols
JP2010514748A (ja) * 2006-12-29 2010-05-06 アーダナ バイオサイエンス リミテッド 組成物の調製方法
WO2011154004A1 (en) * 2010-06-11 2011-12-15 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases
CN102940594A (zh) * 2012-12-04 2013-02-27 艾能赛克机械设备(江苏)有限公司 一种头发调理剂

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021504468A (ja) * 2017-11-27 2021-02-15 ウメクリン コグニチオン アーべー ３α−エチニル−３β−ヒドロキシアンドロスタン−１７−オンオキシムの医薬製剤
JP7314459B2 (ja) 2017-11-27 2023-07-26 ウメクリン コグニチオン アーべー ３α－エチニル－３β－ヒドロキシアンドロスタン－１７－オンオキシムの医薬製剤

Also Published As

Publication number Publication date
CA2912873A1 (en) 2014-12-11
AU2014275195A1 (en) 2015-12-10
CN105263474A (zh) 2016-01-20
WO2014197398A1 (en) 2014-12-11
EP3003272A1 (en) 2016-04-13
MX2015016603A (es) 2016-07-28
AR096459A1 (es) 2015-12-30
HK1223300A1 (zh) 2017-07-28

Similar Documents

Publication Publication Date Title
US10111956B2 (en) Corticosteroid compositions
US10905697B2 (en) Topical formulations comprising a steroid
AU2015385750B2 (en) Topical corticosteroid compositions
KR101121529B1 (ko) 스테로이드의 경시적 안정성이 개선된 외용 제제
JP2016520656A (ja) コルチコステロイド組成物
US11179465B2 (en) Topical compositions comprising a corticosteroid
WO2008126076A2 (en) Low-dose mometasone formulations
CA1182048A (en) Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
CA2376850C (en) Topical formulations comprising skin penetration agents and the use thereof
JP2016520656A5 (enExample)
JP2009029791A (ja) ステロイドを含有するｏ／ｗ型乳化製剤
JP2015193626A (ja) 水中油乳化剤形の医薬組成物及びその製造方法
JP6543945B2 (ja) 乳化組成物
JP2016204371A (ja) 皮膚用の医薬組成物
HK1124771A (en) Preparation for external use having improved temporal stability of steroid
JP2015199730A (ja) 皮膚外用剤の使用性の評価法及び該評価法で使用性に優れると判別される皮膚外用剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170601

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170601

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180320

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180316

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181016